Condition: Nasopharyngeal Cancer · Prostate Cancer · Other Cancer · Sponsor: National Cancer Centre, Singapore
Patients with cancers that are sensitive to radiotherapy treatment and/or patients who have experienced severe acute/ late side effects to radiotherapy will be recruited to the study. Blood and/or matched tumour-normal tissue pairs will be collected. Blood and/or tissue samples will be processed and studied for genetic and biochemical markers that have potential to be used for predicting sensitivity to radiation.
This description comes directly from the study's public registry record.
Melvin Chua, MD · melvin.chua.l.k@singhealth.com.sg
Enya Ong · +65 6436 8000 · enya.ong.h.w@nccs.com.sg
Always discuss trial participation with your own doctor first.
| National Cancer Center Singapore | Singapore, Singapore | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04340024